The verum group showed statistically significant improvements in the domains of physical well-being, fatigue and overall quality of life and less anxiety/depression after intervention compared to placebo. TNF-α and IL-6 were lower in the verum group compared to placebo. The gene discussed is TNF; the disease is depressive symptom measurement.